[Determination of cardiotoxicity of cardiac glycosides in the cat. II. Method of intravenous and intraduodenal infusion assay, planning, execution and evaluation of screening tests].
D000818:Animals; D002301:Cardiac Glycosides / Q000008:administration & dosage / Q000633:toxicity*; D002415:Cats; D004074:Digitoxin / Q000633:toxicity; D004077:Digoxin / Q000633:toxicity; D004386:Duodenum; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects*; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D008297:Male; D008433:Mathematics; D008954:Models, Biological; D010042:Ouabain / Q000633:toxicity; D013223:Statistics as Topic; D013997:Time Factors
D002301:Cardiac Glycosides; D010042:Ouabain; D004077:Digoxin; D004074:Digitoxin
Zur Bestimmung der Cardiotoxizität von Herzglykosiden an der Katze. II. Methodik des intravenösen und intraduodenalen Infusionsversuchs, Planung, Durchführung und Auswertung von Screening-Tests.